RICE JOHN G

Director · AIG, BKR

As of 2026-09-16, RICE JOHN G has 37 Form 4 transactions on record across 2 companies — 16 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $1.7MIndirect: $761K$2.4Mas of 2026-09-16
  • Direct $1.7M
  • Indirect $761K
AIGdirect19,762 sh$1.5M
AIGindirect10,000 sh$761K
BKRdirect2,749 sh$155K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

AIG · 23 trades
2026-07-01: Award / grant, 115 sh2026-07-01: Award / grant, 1,256 sh2026-07-01: Award / grant, 115 sh2026-07-01: Award / grant, 1,256 sh2026-05-13: Award / grant, 2,441 sh2026-05-13: Award / grant, 2,441 sh2026-04-01: Award / grant, 87 sh2026-04-01: Award / grant, 1,273 sh2026-04-01: Award / grant, 87 sh2026-04-01: Award / grant, 1,273 sh2026-01-01: Award / grant, 76 sh2026-01-01: Award / grant, 76 sh2025-10-01: Award / grant, 80 sh2025-10-01: Award / grant, 80 sh2025-07-01: Award / grant, 75 sh2025-07-01: Award / grant, 75 sh2025-05-14: Award / grant, 2,259 sh2025-05-14: Award / grant, 2,259 sh2025-04-01: Award / grant, 56 sh2025-04-01: Award / grant, 56 sh2025-02-13: Purchase, 10,000 sh ($770K)2024-12-31: Award / grant, 66 sh2024-12-31: Award / grant, 66 sh
BKR · 14 trades
2026-05-19: Award / grant, 2,749 sh2026-05-19: Award / grant, 2,749 sh2025-05-20: Award / grant, 4,820 sh2025-05-20: Award / grant, 4,820 sh2024-12-16: Option exercise, 3,303 sh2024-12-16: Award / grant, 3,303 sh2024-12-16: Option exercise, 3,303 sh2024-12-16: Option exercise, 6,377 sh2024-12-16: Option exercise, 3,303 sh2024-12-16: Award / grant, 3,303 sh2024-12-16: Option exercise, 6,377 sh2024-12-16: Option exercise, 3,303 sh2024-12-16: Option exercise, 6,377 sh2024-12-16: Option exercise, 6,377 sh

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-02-13AIGPurchase10,000 @ $77.00$770Kownership Δ n/a10,000Form 4
36 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-07-01AIGAward / grant11519,762Form 4
2026-07-01AIGAward / grant1,25619,647Form 4
2026-07-01AIGAward / grant11519,762Form 4
2026-07-01AIGAward / grant1,25619,647Form 4
2026-05-19BKRAward / grant2,7492,749Form 4
2026-05-19BKRAward / grant2,7492,749Form 4
2026-05-13AIGAward / grant2,44118,391Form 4
2026-05-13AIGAward / grant2,44118,391Form 4
2026-04-01AIGAward / grant8715,950Form 4
2026-04-01AIGAward / grant1,27315,863Form 4
2026-04-01AIGAward / grant8715,950Form 4
2026-04-01AIGAward / grant1,27315,863Form 4
2026-01-01AIGAward / grant7614,590Form 4
2026-01-01AIGAward / grant7614,590Form 4
2025-10-01AIGAward / grant8014,514Form 4
2025-10-01AIGAward / grant8014,514Form 4
2025-07-01AIGAward / grant7514,434Form 4
2025-07-01AIGAward / grant7514,434Form 4
2025-05-20BKRAward / grant4,8204,820Form 4
2025-05-20BKRAward / grant4,8204,820Form 4
2025-05-14AIGAward / grant2,25914,359Form 4
2025-05-14AIGAward / grant2,25914,359Form 4
2025-04-01AIGAward / grant5612,100Form 4
2025-04-01AIGAward / grant5612,100Form 4
2024-12-31AIGAward / grant6612,044Form 4
2024-12-31AIGAward / grant6612,044Form 4
2024-12-16BKROption exercise3,3030Form 4
2024-12-16BKRAward / grant3,3033,303Form 4
2024-12-16BKROption exercise3,30360,938Form 4
2024-12-16BKROption exercise6,37767,315Form 4
2024-12-16BKROption exercise3,3030Form 4
2024-12-16BKRAward / grant3,3033,303Form 4
2024-12-16BKROption exercise6,37767,315Form 4
2024-12-16BKROption exercise3,30360,938Form 4
2024-12-16BKROption exercise6,3770Form 4
2024-12-16BKROption exercise6,3770Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.